Identification of human erythrocyte blood group antigens on decay- accelerating factor (DAF) and an erythrocyte phenotype negative for daf
Authors:
- Se HallSHSe Hall
- Am GreenAGAm Green
- J J MouldsJMJ J Moulds
- W F RosseWRW F Rosse
Open Access
- 1 June 1988
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 167 (6) , 1993-1998
Abstract
Decay accelerating factor (DAF) is a glycoprotein present on the surfaces of many types ofcells in contact with plasma, including erythrocytes, leukocytes, and platelets (reviewed in reference 1). A small amount of DAF is also present in serum. Numerous investigators have demonstrated that DAF inhibits the action of C3 convertases on cell surfaces, and its absence has been shown to be at least partially responsible for the abnormal sensitivity to lysis by complement exhibited by erythrocytes of patients with the acquired stem cell disorder paroxysmal nocturnal hemoglobinuria (PNH) (2). Hereditary absence of DAF has not been previously described. Tc(a) and Cr(a) are high-frequency human erythrocyte antigens . These antigens are part of a family of blood group antigens, designated Cromer related, which are all absent from the null phenotype cell IFC(-) , or Inab (3). Recently, Spring and colleagues (4) have identified two monoclonal antibodies which bound to high frequency red cell antigens absent from the Inab phenotype. They also demonstrated that these antibodies, as well as several human antisera to Cromer-related antigens, bound to a 70-kD glycoprotein when used to stain immunoblots of human erythrocyte membrane proteins . Because the wide tissue distribution of mAb reactivity, along with some of the biochemical characterization and immunoblotting data, was similar to that of DAF, we investigated whether the Cromer-related antigens Cr(a) and Tc(a) resided on the DAF molecule.Keywords
This publication has 13 references indexed in Scilit:
- FURTHER CHARACTERIZATION OF ERYTHROCYTE P80 AND THE MEMBRANE-PROTEIN DEFECT OF IN(LU)LU(A-B-) ERYTHROCYTES1987
- Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.The Journal of Immunology, 1986
- SEPARATION OF THE ACETYLCHOLINESTERASE-DEFICIENT RED-CELLS IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA1986
- The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria.1986
- Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.Proceedings of the National Academy of Sciences, 1985
- Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene.Journal of Clinical Investigation, 1983
- A possible null phenotype in the Cromer blood group complexTransfusion, 1982
- Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.The Journal of Immunology, 1982
- The Lysis of Paroxysmal Nocturnal Haemoglobinuria Red Cells by Serum and Cobra FactorBritish Journal of Haematology, 1972
- Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.Journal of Clinical Investigation, 1966